Covalis Acquires New Stake in Core Scientific
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 58 minutes ago
0mins
Should l Buy CORZ?
Source: Fool
- New Investment Position: Covalis (Gibraltar) Ltd disclosed a new position in Core Scientific by acquiring 2,080,550 shares worth $30.29 million in Q4 2026, indicating strong confidence in the company's future prospects.
- Significant Stake: This acquisition brings Covalis's stake in Core Scientific to 42.7% of its total assets under management, highlighting a strategic focus on the digital asset sector.
- Strong Market Performance: As of last Thursday, Core Scientific shares were priced at $16.24, reflecting an 81% increase over the past year, significantly outperforming the S&P 500's roughly 20% gain, suggesting positive market sentiment.
- Transformation Potential: Core Scientific is repositioning its facilities for high-density colocation and AI workloads, with colocation revenue soaring to $65 million in 2025 from $24 million the previous year, indicating a surge in demand for high-density computing capacity.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CORZ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CORZ
Wall Street analysts forecast CORZ stock price to rise
15 Analyst Rating
14 Buy
1 Hold
0 Sell
Strong Buy
Current: 16.540
Low
19.94
Averages
27.46
High
40.00
Current: 16.540
Low
19.94
Averages
27.46
High
40.00
About CORZ
Core Scientific, Inc. provides digital infrastructure for high-density colocation services and digital asset mining. The Company operates dedicated, purpose-built facilities for digital asset mining and is a provider of digital infrastructure, software solutions and services to its third-party customers. Its Digital Asset Self-Mining segment consists of digital asset mining for its own account. Its Digital Asset Hosted Mining segment consists of its digital infrastructure and third-party hosting services for digital asset mining. Its Colocation segment consists of providing high-density colocation services to third parties for graphics processing units (GPU)-based high-performance computing (HPC) operations. It employs its own large fleet of computers (miners) to earn digital assets for its own account and to provide hosting services for large digital asset-mining customers, and it is in the process of allocating and converting a significant portion of its 10 facilities.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Covalis (Gibraltar) Ltd Increases Stake in Core Scientific
- New Investment Position: Covalis (Gibraltar) Ltd initiated a new position in Core Scientific by acquiring 2,080,550 shares worth $30.29 million in Q4, indicating strong confidence in digital asset infrastructure and likely enhancing its market position in this sector.
- Significant Holding: This acquisition makes Core Scientific the second-largest holding in Covalis's portfolio, representing approximately 43% of its 13F AUM, reflecting the company's importance in Covalis's investment strategy and potentially influencing future investment decisions.
- Business Transformation Potential: Core Scientific is transitioning from bitcoin mining to high-density colocation and AI workloads, with a projected scalable pipeline of about 1.5 gigawatts, indicating a strategic positioning in the rapidly growing AI infrastructure market.
- Substantial Revenue Growth: In 2025, Core Scientific's colocation revenue surged to approximately $65 million, up from about $24 million the previous year, demonstrating rising demand for high-density compute capacity, which could yield significant returns for Covalis's investment.
See More
Covalis Acquires New Stake in Core Scientific
- New Investment Position: Covalis (Gibraltar) Ltd disclosed a new position in Core Scientific by acquiring 2,080,550 shares worth $30.29 million in Q4 2026, indicating strong confidence in the company's future prospects.
- Significant Stake: This acquisition brings Covalis's stake in Core Scientific to 42.7% of its total assets under management, highlighting a strategic focus on the digital asset sector.
- Strong Market Performance: As of last Thursday, Core Scientific shares were priced at $16.24, reflecting an 81% increase over the past year, significantly outperforming the S&P 500's roughly 20% gain, suggesting positive market sentiment.
- Transformation Potential: Core Scientific is repositioning its facilities for high-density colocation and AI workloads, with colocation revenue soaring to $65 million in 2025 from $24 million the previous year, indicating a surge in demand for high-density computing capacity.
See More
CORE SCIENTIFIC INC - TERM LOAN FACILITY EXPIRES 364 DAYS POST-CLOSING DATE - SEC FILING
- Core Scientific Loan Facility: The Core Scientific loan facility has matured 364 days after its closing date.
- SEC Filing: This development has been documented in a filing with the Securities and Exchange Commission (SEC).
See More
CORE SCIENTIFIC INC SECURES $500 MILLION SENIOR LOAN FACILITY THROUGH CREDIT AGREEMENT - SEC FILING
Loan Facility Announcement: Core Scientific has secured a senior secured loan facility amounting to $500 million.
Purpose of the Loan: The loan is intended to provide financial support for the company's operations and growth initiatives.
See More
CORE SCIENTIFIC INC SECURES LOAN FACILITY CREDIT AGREEMENT WITH MORGAN STANLEY SENIOR FUNDING ON MARCH 4 - SEC FILING
Core Scientific's Loan Facility: Core Scientific has entered into a loan facility agreement with Morgan Stanley Senior Funding to secure additional funding.
Financial Strategy: This agreement is part of Core Scientific's strategy to enhance its financial position and support its operations amidst market challenges.
See More
Core Scientific Secures $500 Million Loan Facility to Expand Infrastructure
- Liquidity Enhancement: Core Scientific has completed a $500 million loan agreement with Morgan Stanley, with a 364-day term, significantly strengthening the company's liquidity to support the expansion of its digital infrastructure platform.
- Data Center Expansion Strategy: The financing will be utilized for expanding high-density colocation infrastructure and accelerating data center development, thereby expediting project readiness timelines and enhancing the company's competitive position in the market.
- Increased Financial Flexibility: CEO Adam Sullivan stated that the additional financing capacity will enable the company to operate decisively by deploying capital to expedite project timelines, further solidifying its role as a compelling infrastructure provider.
- Earnings Snapshot: Despite reporting a fourth-quarter adjusted loss of 29 cents and a drop in sales from $94.9 million to $79.76 million, both missing market expectations, the stock has risen 61.54% over the past year, indicating strong investor confidence.
See More
Covalis (Gibraltar) Ltd Increases Stake in Core Scientific
- New Investment Position: Covalis (Gibraltar) Ltd initiated a new position in Core Scientific by acquiring 2,080,550 shares worth $30.29 million in Q4, indicating strong confidence in digital asset infrastructure and likely enhancing its market position in this sector.
- Significant Holding: This acquisition makes Core Scientific the second-largest holding in Covalis's portfolio, representing approximately 43% of its 13F AUM, reflecting the company's importance in Covalis's investment strategy and potentially influencing future investment decisions.
- Business Transformation Potential: Core Scientific is transitioning from bitcoin mining to high-density colocation and AI workloads, with a projected scalable pipeline of about 1.5 gigawatts, indicating a strategic positioning in the rapidly growing AI infrastructure market.
- Substantial Revenue Growth: In 2025, Core Scientific's colocation revenue surged to approximately $65 million, up from about $24 million the previous year, demonstrating rising demand for high-density compute capacity, which could yield significant returns for Covalis's investment.
See More
Covalis Acquires New Stake in Core Scientific
- New Investment Position: Covalis (Gibraltar) Ltd disclosed a new position in Core Scientific by acquiring 2,080,550 shares worth $30.29 million in Q4 2026, indicating strong confidence in the company's future prospects.
- Significant Stake: This acquisition brings Covalis's stake in Core Scientific to 42.7% of its total assets under management, highlighting a strategic focus on the digital asset sector.
- Strong Market Performance: As of last Thursday, Core Scientific shares were priced at $16.24, reflecting an 81% increase over the past year, significantly outperforming the S&P 500's roughly 20% gain, suggesting positive market sentiment.
- Transformation Potential: Core Scientific is repositioning its facilities for high-density colocation and AI workloads, with colocation revenue soaring to $65 million in 2025 from $24 million the previous year, indicating a surge in demand for high-density computing capacity.
See More
CORE SCIENTIFIC INC - TERM LOAN FACILITY EXPIRES 364 DAYS POST-CLOSING DATE - SEC FILING
- Core Scientific Loan Facility: The Core Scientific loan facility has matured 364 days after its closing date.
- SEC Filing: This development has been documented in a filing with the Securities and Exchange Commission (SEC).
See More
CORE SCIENTIFIC INC SECURES $500 MILLION SENIOR LOAN FACILITY THROUGH CREDIT AGREEMENT - SEC FILING
Loan Facility Announcement: Core Scientific has secured a senior secured loan facility amounting to $500 million.
Purpose of the Loan: The loan is intended to provide financial support for the company's operations and growth initiatives.
See More
CORE SCIENTIFIC INC SECURES LOAN FACILITY CREDIT AGREEMENT WITH MORGAN STANLEY SENIOR FUNDING ON MARCH 4 - SEC FILING
Core Scientific's Loan Facility: Core Scientific has entered into a loan facility agreement with Morgan Stanley Senior Funding to secure additional funding.
Financial Strategy: This agreement is part of Core Scientific's strategy to enhance its financial position and support its operations amidst market challenges.
See More
Core Scientific Secures $500 Million Loan Facility to Expand Infrastructure
- Liquidity Enhancement: Core Scientific has completed a $500 million loan agreement with Morgan Stanley, with a 364-day term, significantly strengthening the company's liquidity to support the expansion of its digital infrastructure platform.
- Data Center Expansion Strategy: The financing will be utilized for expanding high-density colocation infrastructure and accelerating data center development, thereby expediting project readiness timelines and enhancing the company's competitive position in the market.
- Increased Financial Flexibility: CEO Adam Sullivan stated that the additional financing capacity will enable the company to operate decisively by deploying capital to expedite project timelines, further solidifying its role as a compelling infrastructure provider.
- Earnings Snapshot: Despite reporting a fourth-quarter adjusted loss of 29 cents and a drop in sales from $94.9 million to $79.76 million, both missing market expectations, the stock has risen 61.54% over the past year, indicating strong investor confidence.
See More
